A review on potential of PARP inhibitors in the treatment of prostate cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
मुख्य लेखक: | Islam, Saidul |
---|---|
अन्य लेखक: | Sharmin, Shahana |
स्वरूप: | थीसिस |
भाषा: | English |
प्रकाशित: |
Brac University
2022
|
विषय: | |
ऑनलाइन पहुंच: | http://hdl.handle.net/10361/17308 |
समान संसाधन
-
A review on newly approved PARP inhibitors: Talazoparib and Olaparib
द्वारा: Karim, Azrin
प्रकाशित: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
द्वारा: Flora, Sanzida Alam
प्रकाशित: (2024) -
SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
द्वारा: Meem, Manila
प्रकाशित: (2023) -
Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
द्वारा: Alam, Tahera
प्रकाशित: (2024) -
RIPK pathway, as a potential target, for cancer treatment - a review
द्वारा: Jahan, Nusrat
प्रकाशित: (2024)